Ann: Imagion announces HREC approval for Phase I study, page-156

Yes I think they are already assuming human trials is more for shareholders and the like and could very know it’s a winner. Given that they are already trialing for ovarian cancer, prostate and possibly others. Would have thought this is showing confidence. If they were not more than positive it would be a success in breast cancer human trials, then why waste the $$$”s on any others. Just a thought.

However I’d think with haven been given the gold star to be fast tracked, then things might happen quickly. Either way I don’t see the point in worrying about a fall back to 7c or a climb to 20c in the next month.

The last episode on IBX hospital, starring our amazing CEO. Who mind you is out of retirement for this season of IBX to the moon.

This latest episode gave insight into a world of opportunity’s with huge multinational companies, not just the obvious one. He said this could change the medical industry! Huge!

So don’t worry about the cents! If you believe in the research we have data from already and interested multinationals, (list will grow over the next 3-6 months). Worry about how many $$$$”s you will sell out at, or even better keep for dividends!

So much news to come. Each group will be assessed along the way and data shared with the WORLD! A lot of eyes age corporations, brokers etc, will be watching. So the first group could be assed in what 2-3 months I’m not sure.

Then feedback on success in ovarian, prostate and bowel etc. Which should go smoothly if so effective so far on breast.

Either way, sky is the limit with this baby!